Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Immunoturbidimetric Test for D-Dimer Performed on Clinical Chemistry Systems

By LabMedica International staff writers
Posted on 05 May 2009
A newly designed particle-enhanced immunoturbidimetric test for D-Dimer is designed for use on automated clinical chemistry systems. More...
D-Dimer tests are used for exclusion of deep vein thrombosis (DVT) of the leg.

The new D-Dimer FS immunoturbidimetric test has a cut-off value of 0.5 µg FEU/ml (fibrinogen equivalent units per milliliter) and shows good diagnostic sensitivity ensuring that 98 % of patients with DVT are found true-positive. The two-component reagent is liquid-stable and ready to use. The test covers a wide measuring range up to 8.7 µg FEU/ml and stands out for its high prozone security up to 50 µg FEU/ml. D-Dimer FS shows excellent calibration and on-board stability up to six weeks.

D-Dimer FS is a product of DiaSys Diagnostic Systems (Holzheim, Germany), a company that develops, manufactures, and distributes a full range of diagnostic reagents for clinical chemistry and including controls and calibrators. The company focuses on liquid-stable, ready-to-use reagents for measurement of enzymes and substrates, and immunoturbidimetric tests for the measurement of specific proteins.

The company's current product range lists more than 80 reagents in convenient packages for routine and special diagnostics on photometers or automated analyzers. The product range is completed by clinical chemistry analyzers and point-of-care instruments for diabetes monitoring.

Related Links:

DiaSys Diagnostic Systems





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Urine Analyzer
respons® UDS100
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.